-6%巨震！北交究竟该如何生存？

Core Viewpoint - The recent significant decline in the Beijing Stock Exchange (BSE) is attributed to the overvaluation of key stocks and insufficient trading volume, leading to a market correction [1][5][6]. Group 1: Market Performance - Only 21 stocks rose in the recent market downturn, with the "BSE 50" index dropping by 6.15% and the "BSE All A" index falling by 5.62%, marking the largest single-day decline of the year, excluding the "reciprocal tariffs" event [1]. - The stock "Jinbo Biological" (832982.BJ) significantly influenced the index, having risen over 150% since March, leading to a valuation of over 60 times earnings, prompting profit-taking and contributing to the index's decline [2][4]. Group 2: Trading Volume and Market Dynamics - The trading volume during the recent rally was insufficient to support new highs, with the BSE All A index not surpassing previous highs despite a notable increase since early April [4]. - A lack of strong market leaders following the end of speculative trading in certain sectors has led to a predictable market retreat, as indicated by various objective indicators [6]. Group 3: Investor Sentiment and Future Outlook - Historical patterns suggest that significant declines are not uncommon in the BSE, and the current environment may not lead to prolonged downturns, presenting potential buying opportunities [5]. - The recent spike in trading volume for the CSI 2000 index raised concerns about a repeat of past market behaviors, contributing to heightened fear and accelerating the market's decline [7].